Cytokines and chemokines in immune-based ocular surface inflammation

References

• Calonge M. Classification of ocular atopic/allergic disorders and conditions: an unsolved problem. Acta Ophthalmol. Scand.228(Suppl.), 10–13 (1999).
   Google Scholar
• Pflugfelder SC. Anti-inflammatory therapy of dry eye. Ocul. Surf.1(1), 31–36 (2003).
   PubMedGoogle Scholar
• Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea17(6), 584–589 (1998).
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Historical insights into cytokines. Eur. J. Immunol.37(Suppl. 1), S34–S45 (2007).
   PubMed Web of Science ®Google Scholar
• Stern ME, Siemasko K, Gao J et al. Role of interferon-γ in a mouse model of allergic conjunctivitis. Invest. Ophthalmol. Vis. Sci.46(9), 3239–3246 (2005).
   PubMed Web of Science ®Google Scholar
• Stern ME, Siemasko KF, Niederkorn JY. The Th1/Th2 paradigm in ocular allergy. Curr. Opin. Allergy Clin. Immunol.5(5), 446–450 (2005).
   PubMedGoogle Scholar
• Leonardi A, Fregona IA, Plebani M, Secchi AG, Calder VL. Th1- and Th2-type cytokines in chronic ocular allergy. Graefes Arch. Clin. Exp. Ophthalmol.244(10), 1240–1245 (2006).
   PubMedGoogle Scholar
• Leonardi A, De Dominicis C, Motterle L. Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities. Curr. Opin. Allergy Clin. Immunol.7(5), 429–435 (2007).
   PubMed Web of Science ®Google Scholar
• Pease JE, Williams TJ. Chemokines and their receptors in allergic disease. J. Allergy Clin. Immunol.118(2), 305–318 (2006).
   PubMed Web of Science ®Google Scholar
• D’Ambrosio D, Panina-Bordignon P, Sinigaglia F. Chemokine receptors in inflammation: an overview. J. Immunol. Methods273(1–2), 3–13 (2003).
   PubMed Web of Science ®Google Scholar
• Calder VL, Lackie PM. Basic science and pathophysiology of ocular allergy. Curr. Allergy Asthma Rep.4(4), 326–331 (2004).
   Google Scholar
• Stahl JL, Barney NP. Ocular allergic disease. Curr. Opin. Allergy Clin. Immunol.4(5), 455–459 (2004).
   PubMedGoogle Scholar
• Calder VL, Jolly G, Hingorani M et al. Cytokine production and mRNA expression by conjunctival T-cell lines in chronic allergic eye disease. Clin. Exp. Allergy29(9), 1214–1222 (1999).
   PubMed Web of Science ®Google Scholar
• Hingorani M, Calder V, Jolly G, Buckley RJ, Lightman SL. Eosinophil surface antigen expression and cytokine production vary in different ocular allergic diseases. J. Allergy Clin. Immunol.102(5), 821–830 (1998).
   PubMed Web of Science ®Google Scholar
• Hingorani M, Calder VL, Buckley RJ, Lightman SL. The role of conjunctival epithelial cells in chronic ocular allergic disease. Exp. Eye Res.67(5), 491–500 (1998).
   PubMed Web of Science ®Google Scholar
• Bisset LR, Schmid-Grendelmeier P. Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective. Curr. Opin. Pulm. Med.11(1), 35–42 (2005).
   PubMed Web of Science ®Google Scholar
• Pease JE. Asthma, allergy and chemokines. Curr. Drug Targets7(1), 3–12 (2006).
   PubMed Web of Science ®Google Scholar
• Davies DE, Holgate ST. Asthma: the importance of epithelial mesenchymal communication in pathogenesis. Inflammation and the airway epithelium in asthma. Int. J. Biochem. Cell Biol.34(12), 1520–1526 (2002).
   Google Scholar
• Holgate ST, Davies DE, Lackie PM, Wilson SJ, Puddicombe SM, Lordan JL. Epithelial-mesenchymal interactions in the pathogenesis of asthma. J. Allergy Clin. Immunol.105(2 Pt 1), 193–204 (2000).
   PubMed Web of Science ®Google Scholar
• Diebold Y, Calonge M, Carretero V, Fernandez N, Herreras JM. Expression of ICAM-1 and HLA-DR by human conjunctival epithelial cultured cells and modulation by nedocromil sodium. J. Ocul. Pharmacol. Ther.14(6), 517–531 (1998).
   Google Scholar
• Irkec M, Bozkurt B. Epithelial cells in ocular allergy. Curr. Allergy Asthma Rep.3(4), 352–357 (2003).
   Google Scholar
• Zhan H, Towler HM, Calder VL. The immunomodulatory role of human conjunctival epithelial cells. Invest. Ophthalmol. Vis. Sci.44(9), 3906–3910 (2003).
   Google Scholar
• Diebold Y, Calonge M, Enriquez de Salamanca A et al. Characterization of a spontaneously immortalized cell line (IOBA-NHC) from normal human conjunctiva. Invest. Ophthalmol. Vis. Sci.44(10), 4263–4274 (2003).
   PubMedGoogle Scholar
• Gao J, Siemasko KF, Diebold Y et al. In vitro models of ocular inflammation using normal conjunctival cells. Invest. Ophthalmol. Vis. Sci.44, E-abstract 683 (2003).
   Google Scholar
• Stahl JL, Cook EB, Graziano FM, Barney NP. Differential and cooperative effects of TNF α, IL-1β, and IFN γ on human conjunctival epithelial cell receptor expression and chemokine release. Invest. Ophthalmol. Vis. Sci.44(5), 2010–2015 (2003).
   Google Scholar
• Calonge M, Enriquez-de-Salamanca A. The role of the conjunctival epithelium in ocular allergy. Curr. Opin. Allergy Clin. Immunol.5(5), 441–445 (2005).
   Google Scholar
• Siemasko KF, Gao J, Enriquez-de-Salamanca A. Inflammatory cytokine effects on co-stimulatory molecule and chemokines expression in the human conjunctival epithelial cell line, IOBA-NHC. Invest. Ophthalmol. Vis. Sci.46, E-abstract 2687 (2005).
   Google Scholar
• Enríquez de Salamanca A, Siemasko KF, Diebold Y et al. Expression of muscarinic and adrenergic receptors in normal human conjunctival epithelium. Invest. Ophthalmol. Vis. Sci.46(2), 504–513 (2005).
   Google Scholar
• Motterle L, Diebold Y, Enriquez de Salamanca A et al. Altered expression of neurotransmitter receptors and neuromediators in vernal keratoconjunctivitis. Arch. Ophthalmol.124(4), 462–468 (2006).
   PubMedGoogle Scholar
• Calonge M, De Salamanca AE, Siemasko KF et al. Variation in the expression of inflammatory markers and neuroreceptors in human conjunctival epithelial cells. Ocul. Surf.3(4 Suppl.), S145–S148 (2005).
   Google Scholar
• Enríquez-de-Salamanca A, Gao J, Calder V et al. Cytokine/chemokine secretion by human conjunctival epithelial cells stimulated with Th1- or Th2-derived cytokines. Invest.Ophthalmol.Vis.Sci.47, E-abstract 4937 (2006).
   Google Scholar
• Calonge M, Enríquez-de-Salamanca A, Garcia-Vazquez C, Stern ME. Specific patterns of conjunctival epithelial barrier alteration induced by Th1 versus Th2 cytokines. Invest. Ophthalmol. Vis. Sci.47, 4938 (2006) (E-abstract).
   Google Scholar
• Kumagai N, Fukuda K, Fujitsu Y, Yamamoto K, Nishida T. Role of structural cells of the cornea and conjunctiva in the pathogenesis of vernal keratoconjunctivitis. Prog. Retin. Eye Res.25(2), 165–187 (2006).
   PubMed Web of Science ®Google Scholar
• Fukagawa K, Nakajima T, Tsubota K, Shimmura S, Saito H, Hirai K. Presence of eotaxin in tears of patients with atopic keratoconjunctivitis with severe corneal damage. J. Allergy Clin. Immunol.103(6), 1220–1221 (1999).
   PubMed Web of Science ®Google Scholar
• Leonardi A, Jose PJ, Zhan H, Calder VL. Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis. Ophthalmology110(3), 487–492 (2003).
   PubMed Web of Science ®Google Scholar
• Fukuda K, Fujitsu Y, Seki K, Kumagai N, Nishida T. Differential expression of thymus- and activation-regulated chemokine (CCL17) and macrophage-derived chemokine (CCL22) by human fibroblasts from cornea, skin, and lung. J. Allergy Clin. Immunol.111(3), 520–526 (2003).
   PubMedGoogle Scholar
• Fukuda K, Kumagai N, Fujitsu Y, Nishida T. Fibroblasts as local immune modulators in ocular allergic disease. Allergol. Int.55(2), 121–129 (2006).
   PubMedGoogle Scholar
• Uchio E, Ono SY, Ikezawa Z, Ohno S. Tear levels of interferon-γ, interleukin (IL)-2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis. Clin. Exp. Allergy30(1), 103–109 (2000).
   PubMed Web of Science ®Google Scholar
• Sack R, Conradi L, Beaton A, Sathe S, McNamara N, Leonardi A. Antibody array characterization of inflammatory mediators in allergic and normal tears in the open and closed eye environments. Exp. Eye Res.85(4), 528–538 (2007).
   PubMedGoogle Scholar
• Shoji J, Inada N, Sawa M. Antibody array-generated cytokine profiles of tears of patients with vernal keratoconjunctivitis or giant papillary conjunctivitis. Jpn. J. Ophthalmol.50(3), 195–204 (2006).
   PubMed Web of Science ®Google Scholar
• Shoji J, Kawaguchi A, Gotoh A, Inada N, Sawa M. Concentration of soluble interleukin-6 receptors in tears of allergic conjunctival disease patients. Jpn. J. Ophthalmol.51(5), 332–337 (2007).
   Web of Science ®Google Scholar
• Cook EB, Stahl JL, Lowe L et al. Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics. J. Immunol. Methods254(1–2), 109–118 (2001).
   PubMed Web of Science ®Google Scholar
• Cook EB. Tear cytokines in acute and chronic ocular allergic inflammation. Curr. Opin. Allergy Clin. Immunol.4(5), 441–445 (2004).
   PubMed Web of Science ®Google Scholar
• Nivenius E, Montan PG, Chryssanthou E, Jung K, van Hage-Hamsten M, van der Ploeg I. No apparent association between periocular and ocular microcolonization and the degree of inflammation in patients with atopic keratoconjunctivitis. Clin. Exp. Allergy34(5), 725–730 (2004).
   PubMed Web of Science ®Google Scholar
• Leonardi A, Curnow J, Calder VL. Multiple cytokine evaluation in tears of allergic conjunctivitis patients by multiple-cytokine bead assay. Invest. Ophthalmol. Vis. Sci.45, E-abstract 625 (2004).
   Google Scholar
• Sarac O, Erdener U, Irkec M, Us D, Gungen Y. Tear eotaxin levels in giant papillary conjunctivitis associated with ocular prosthesis. Ocul. Immunol. Inflamm.11(3), 223–230 (2003).
   PubMed Web of Science ®Google Scholar
• Leonardi A, Curnow SJ, Zhan H, Calder VL. Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures. Clin. Exp. Allergy36(6), 777–784 (2006).
   PubMed Web of Science ®Google Scholar
• The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul. Surf.5(2), 75–92 (2007).
   PubMed Web of Science ®Google Scholar
• Stern ME, Gao J, Siemasko KF, Beuerman RW, Pflugfelder SC. The role of the lacrimal functional unit in the pathophysiology of dry eye. Exp. Eye Res.78(3), 409–416 (2004).
   PubMed Web of Science ®Google Scholar
• Pflugfelder SC, Beuerman RW, Stern ME. Dry Eye and Ocular Surface Disorders. Marcel Dekker, Informa Healthcare, London, UK (2004).
   Google Scholar
• Jones DT, Monroy D, Ji Z, Atherton SS, Pflugfelder SC. Sjogren’s syndrome: cytokine and Epstein–Barr viral gene expression within the conjunctival epithelium. Invest. Ophthalmol. Vis. Sci.35(9), 3493–3504 (1994).
   PubMed Web of Science ®Google Scholar
• Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren’s syndrome keratoconjunctivitis sicca. Curr. Eye Res.19(3), 201–211 (1999).
   PubMed Web of Science ®Google Scholar
• Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest. Ophthalmol. Vis. Sci.42(10), 2283–2292 (2001).
   PubMed Web of Science ®Google Scholar
• Tishler M, Yaron I, Geyer O, Shirazi I, Naftaliev E, Yaron M. Elevated tear interleukin-6 levels in patients with Sjogren syndrome. Ophthalmology105(12), 2327–2329 (1998).
   PubMed Web of Science ®Google Scholar
• Yoon KC, Jeong IY, Park YG, Yang SY. Interleukin-6 and tumor necrosis factor-α levels in tears of patients with dry eye syndrome. Cornea26(4), 431–437 (2007).
   PubMed Web of Science ®Google Scholar
• Corrales RM, Villarreal A, Farley W, Stern ME, Li DQ, Pflugfelder SC. Strain-related cytokine profiles on the murine ocular surface in response to desiccating stress. Cornea26(5), 579–584 (2007).
   PubMed Web of Science ®Google Scholar
• Gorham JD, Guler ML, Steen RG et al. Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses. Proc. Natl Acad. Sci. USA93(22), 12467–12472 (1996).
   PubMedGoogle Scholar
• Yoon KC, De Paiva CS, Qi H et al. Expression of Th-1 chemokines and chemokine receptors on the ocular surface of C57BL/6 mice: effects of desiccating stress. Invest. Ophthalmol. Vis. Sci.48(6), 2561–2569 (2007).
   PubMed Web of Science ®Google Scholar
• Narayanan S, Miller WL, McDermott AM. Conjunctival cytokine expression in symptomatic moderate dry eye subjects. Invest. Ophthalmol. Vis. Sci.47(6), 2445–2450 (2006).
   PubMed Web of Science ®Google Scholar
• Wong EK, Dang QN, Siemasko K et al. Cytokine study of the denervated rat model of dry eye. Invest. Ophthalmol. Vis. Sci.49, 334 (2008) (E-abstract).
   Google Scholar
• De Paiva CS, Chotikavanich S, Pangelinan S et al. Desiccating stress promotes Th-17 pattern response in the conjuntiva. Invest. Ophthalmol. Vis. Sci.49, E-abstract 5420 (2008).
   Google Scholar
• Pflugfelder SC, Stern ME. Future directions in therapeutic interventions for conjunctival inflammatory disorders. Curr. Opin. Allergy Clin. Immunol.7(5), 450–453 (2007).
   PubMed Web of Science ®Google Scholar
• Elliott J, Johnston JA. SOCS: role in inflammation, allergy and homeostasis. Trends Immunol.25(8), 434–440 (2004).
   PubMedGoogle Scholar
• Hebenstreit D, Luft P, Schmiedlechner A, Duschl A, Horejs-Hoeck J. SOCS-1 and SOCS-3 inhibit IL-4 and IL-13 induced activation of eotaxin-3/CCL26 gene expression in HEK293 cells. Mol. Immunol.42(3), 295–303 (2005).
   PubMedGoogle Scholar
• Seki Y, Inoue H, Nagata N et al. SOCS-3 regulates onset and maintenance of Th2-mediated allergic responses. Nat. Med.9(8), 1047–1054 (2003).
   PubMed Web of Science ®Google Scholar
• Horiuchi Y, Bae SJ, Katayama I. Overexpression of the suppressor of cytokine signalling 3 (SOCS3) in severe atopic dermatitis. Clin. Exp. Dermatol.31(1), 100–104 (2006).
   Google Scholar
• Ozaki A, Seki Y, Fukushima A, Kubo M. The control of allergic conjunctivitis by suppressor of cytokine signaling (SOCS)3 and SOCS5 in a murine model. J. Immunol.175(8), 5489–5497 (2005).
   PubMed Web of Science ®Google Scholar
• Kubo M, Ozaki A, Tanaka S, Okamoto M, Fukushima A. Role of suppressor of cytokine signaling in ocular allergy. Curr. Opin. Allergy Clin. Immunol.6(5), 361–366 (2006).
   Google Scholar
• Shen HH, Xu F, Zhang GS, Wang SB, Xu WH. CCR3 monoclonal antibody inhibits airway eosinophilic inflammation and mucus overproduction in a mouse model of asthma. Acta Pharmacol. Sin.27(12), 1594–1599 (2006).
   Google Scholar
• Wegmann M, Goggel R, Sel S et al. Effects of a low-molecular-weight CCR-3 antagonist on chronic experimental asthma. Am. J. Respir. Cell Mol. Biol.36(1), 61–67 (2007).
   PubMed Web of Science ®Google Scholar
• Wang K, Shen HH, Li W, Huang HQ. Human C-C chemokine receptor 3 monoclonal antibody inhibits pulmonary inflammation in allergic mice. Acta Pharmacol. Sin.28(11), 1791–1796 (2007).
   Google Scholar
• Fukagawa K, Okada N, Fujishima H et al. CC-chemokine receptor 3: a possible target in treatment of allergy-related corneal ulcer. Invest. Ophthalmol. Vis. Sci.43(1), 58–62 (2002).
   PubMedGoogle Scholar
• Gulati A, Sacchetti M, Bonini S, Dana R. Chemokine receptor CCR5 expression in conjunctival epithelium of patients with dry eye syndrome. Arch. Ophthalmol.124(5), 710–716 (2006).
   Google Scholar
• Hida RY, Takano Y, Okada N et al. Suppressive effects of tranilast on eotaxin-1 production from cultured conjunctival fibroblasts. Curr. Eye Res.33(1), 19–22 (2008).
   PubMed Web of Science ®Google Scholar
• Cook EB, Stahl JL, Barney NP, Graziano FM. Olopatadine inhibits TNFa release from human conjunctival mast cells. Ann. Allergy Asthma Immunol.84(5), 504–508 (2000).
   PubMed Web of Science ®Google Scholar
• Cook EB, Stahl JL, Brooks AM, Graziano FM, Barney NP. Allergic tears promote upregulation of eosinophil adhesion to conjunctival epithelial cells in an ex vivo model: inhibition with olopatadine treatment. Invest. Ophthalmol. Vis. Sci.47(8), 3423–3429 (2006).
   PubMedGoogle Scholar
• Cook EB, Stahl JL, Sedgwick JB, Barney NP, Graziano FM. The promotion of eosinophil degranulation and adhesion to conjunctival epithelial cells by IgE-activated conjunctival mast cells. Ann. Allergy Asthma Immunol.92(1), 65–72 (2004).
   PubMed Web of Science ®Google Scholar
• Galatowicz G, Ajayi Y, Stern ME, Calder VL. Ocular anti-allergic compounds selectively inhibit human mast cell cytokines in vitro and conjunctival cell infiltration in vivo. Clin. Exp. Allergy37(11), 1648–1656 (2007).
   PubMed Web of Science ®Google Scholar
• Pauly A, Brignole-Baudouin F, Guenoun JM et al. Comparative study of topical anti-allergic eye drops on human conjunctiva-derived cells: responses to histamine and IFN γ and toxicological profiles. Graefes Arch. Clin. Exp. Ophthalmol.245(4), 534–546 (2007).
   PubMedGoogle Scholar
• Pflugfelder SC, De Paiva CS, Villarreal AL, Stern ME. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-β2 production. Cornea27(1), 64–69 (2008).
   PubMed Web of Science ®Google Scholar
• Steinfeld SD, Demols P, Appelboom T. Infliximab in primary Sjogren’s syndrome: one-year followup. Arthritis Rheum.46(12), 3301–3303 (2002).
   PubMed Web of Science ®Google Scholar
• Mariette X, Ravaud P, Steinfeld S et al. Inefficacy of infliximab in primary Sjogren’s syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjogren’s Syndrome (TRIPSS). Arthritis Rheum.50(4), 1270–1276 (2004).
   PubMed Web of Science ®Google Scholar
• Sankar V, Brennan MT, Kok MR et al. Etanercept in Sjogren’s syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial. Arthritis Rheum.50(7), 2240–2245 (2004).
   PubMed Web of Science ®Google Scholar
• Zandbelt MM, de Wilde P, van DP, Hoyng CB, van de Putte L, van den Hogen F. Etanercept in the treatment of patients with primary Sjogren’s syndrome: a pilot study. J. Rheumatol.31(1), 96–101 (2004).
   PubMed Web of Science ®Google Scholar
• Narayanan S, Glasser A, Hu YS, McDermott AM. The effect of interleukin-1 on cytokine gene expression by human corneal epithelial cells. Exp. Eye Res.80(2), 175–183 (2005).
   PubMedGoogle Scholar
• Kalliolias GD, Liossis SN. The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still’s disease and systemic-onset juvenile idiopathic arthritis. Exp. Opin. Investig. Drugs17(3), 349–359 (2008).
   PubMed Web of Science ®Google Scholar
• Keane-Myers AM, Miyazaki D, Liu G, Dekaris I, Ono S, Dana MR. Prevention of allergic eye disease by treatment with IL-1 receptor antagonist. Invest. Ophthalmol. Vis. Sci.40(12), 3041–3046 (1999).
   PubMed Web of Science ®Google Scholar